LAMEA In Situ Hybridization Market

LAMEA In Situ Hybridization Market Size, Share & Industry Trends Analysis Report By Technology, By End Use (Research & Diagnostic Laboratories, Academic Institutes, CROs), By Application, By Product, By Probe, By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-13369 Publication Date: January-2023 Number of Pages: 113
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Latin America, Middle East and Africa In Situ Hybridization Market would witness market growth of 10.3% CAGR during the forecast period (2022-2028).

The fundamentals of nucleic acid hybridization that underpin Southern blotting and in situ hybridization are the same. Using a complementary, labeled nucleic acid probe, mRNA signals may be found in tissues that have been appropriately maintained.

Due to the thermodynamic stability of RNA-RNA duplexes, single-stranded RNA probes (riboprobes) are typically preferred. The methodology has been used on various Populus, Eucalyptus, and Pinus tissues. It may be modified further with different labeling and detection techniques or extended to additional species/tissues.

Saudi Arabia mostly finances healthcare spending in the Gulf Cooperation Council (GCC), and the Saudi government continues to place a high premium on the industry. The Saudi Arabian government has budgeted about $65 billion to develop the healthcare system as part of Vision 2030. Additionally, it wants to privatize 290 hospitals and 2,300 primary health clinics by 2030, increasing private sector participation from 40% to 65%. Due to the region's increasing healthcare infrastructure, vendors in the in-situ hybridization market would have many possibilities to invest in the LAMEA area.

The Brazil market dominated the LAMEA In Situ Hybridization Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $28.8 million by 2028.The Argentina market is experiencing a CAGR of 10.9% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 10% during (2022 - 2028).

Based on Technology, the market is segmented into Fluorescent In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH). Based on End Use, the market is segmented into Research & Diagnostic Laboratories, Academic Institutes, CROs and Others. Based on Application, the market is segmented into Cancer, Cytogenetics, Developmental Biology, Infectious Diseases and Others. Based on Product, the market is segmented into Instruments, Kits & Probes, Software and Services. Based on Probe, the market is segmented into DNA and RNA. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global In Situ Hybridization Market is Predict to reach $1.8 Billion by 2028, at a CAGR of 6.9%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Abbott Laboratories, PerkinElmer, Inc., Agilent Technologies, Inc., Merck Group, Bio-Rad Laboratories, Inc., Bio-Techne Corporation (Advanced Cell Diagnostics, Inc.), Danaher Corporation (Leica Biosystems), F. Hoffmann-La Roche Ltd., and Neogenomics, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Technology

  • Fluorescent In Situ Hybridization (FISH)
  • Chromogenic In Situ Hybridization (CISH)

By End Use

  • Research & Diagnostic Laboratories
  • Academic Institutes
  • CROs
  • Others

By Application

  • Cancer
  • Cytogenetics
  • Developmental Biology
  • Infectious Diseases
  • Others

By Product

  • Instruments
  • Kits & Probes
  • Software
  • Services

By Probe

  • DNA
  • RNA

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific, Inc.
  • Abbott Laboratories
  • PerkinElmer, Inc.
  • Agilent Technologies, Inc.
  • Merck Group
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation (Advanced Cell Diagnostics, Inc.)
  • Danaher Corporation (Leica Biosystems)
  • F. Hoffmann-La Roche Ltd.
  • Neogenomics, Inc.
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo